The small molecule inhibitor CCT196969 has been shown to inhibit tumor cell proliferation, survival, and metastasis in melanoma and colorectal cancer by targeting and inhibiting the RAS/RAF/MEK/ERK signaling pathway. This evidence concerns the gene MAP2K7 and colorectal cancer.